These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1159 related items for PubMed ID: 25257544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
    Rock EM, Sticht MA, Duncan M, Stott C, Parker LA.
    Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
    [Abstract] [Full Text] [Related]

  • 4. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG.
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors.
    Raïch I, Rivas-Santisteban R, Lillo A, Lillo J, Reyes-Resina I, Nadal X, Ferreiro-Vera C, de Medina VS, Majellaro M, Sotelo E, Navarro G, Franco R.
    Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.
    Navarro G, Varani K, Lillo A, Vincenzi F, Rivas-Santisteban R, Raïch I, Reyes-Resina I, Ferreiro-Vera C, Borea PA, Sánchez de Medina V, Nadal X, Franco R.
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct 03; 79(Pt B):369-377. PubMed ID: 28720466
    [Abstract] [Full Text] [Related]

  • 13. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB.
    Br J Pharmacol; 2019 May 03; 176(10):1455-1469. PubMed ID: 29981240
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14136-41. PubMed ID: 10570211
    [Abstract] [Full Text] [Related]

  • 15. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH, Galaj E, He Y, Xi ZX.
    Addict Biol; 2020 Jul 23; 25(4):e12783. PubMed ID: 31215752
    [Abstract] [Full Text] [Related]

  • 16. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG, Hallak JEC, Crippa JAS.
    Adv Exp Med Biol; 2021 Jul 23; 1264():29-45. PubMed ID: 33332002
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE, Friedman D.
    Epilepsy Behav; 2017 May 23; 70(Pt B):313-318. PubMed ID: 28087250
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.
    PLoS One; 2020 May 23; 15(2):e0228909. PubMed ID: 32049991
    [Abstract] [Full Text] [Related]

  • 19. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
    Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R.
    Biochem Pharmacol; 2018 Nov 23; 157():148-158. PubMed ID: 30194918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.